6550-01-542-3777 ( 333180 )
NSN Information
NSN | FSC | NIIN | Item Name | INC |
---|---|---|---|---|
6550-01-542-3777 | 6550 | 015423777 | REAGENT SET,BLOOD GROUPING TEST | 3669 |
NSN Features
MRC | Parameter | Characteristics |
---|---|---|
CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | BD ONCOMARK ANTI-HLA-DR FITC/CD13 PE |
FEAT | SPECIAL FEATURES | BD ONCOMARK ANTI-HLA-DR FITC/CD13 PE IS INTENDED FOR IN VITRO FLOW CYTOMETRIC IMMUNOPHENOTYPING THIS REAGENT COMBINATION CAN BE USED TO ANALYZE MYELOID LINEAGE DEVELOPMENT;ANTI-HLA-DR AND CD13 ASSAYS ARE USED IN THE DIAGNOSIS OF HEMATOLOGIC DISORDERS;THE ANTIBODY REAGENT IS STABLE UNTIL THE EXPIRATION DATE SHOWN ON THE LABEL WHEN STORED AT 2 TO 8 DEGREE CELSIUS;BD ONCOMARK ANTI-HLA-DR FITC/CD13 PE CAN BE USED FOR IMMUNOPHENOTYPING BY FLOW CYTOMETRY WOTH PERIPHERAL BLOOD AND BONE MARROW ASPIRATES COLLECTED IN EDTA (EG,BD VACUTAINER TUBES);EACH TYPE OF SPECIMEN CAN HAVE DIFFERENT STORAGE CONDITIONS AND LIMITATIONS THAT SHOULD BE CONSIDERED PRIOR TO COLLECTION AND ANALYSIS |
Manufacturing Part Numbers (SKUs)
Part SKU | Cage | Status | RNVC | RNCC | SADC | DAC | RNAAC |
---|---|---|---|---|---|---|---|
333180 | 0GKS0 | A | 2 | 3 | 4 | 9Z |
Manufacturers
Part SKU | Cage | Manufacturer | Type | Status |
---|---|---|---|---|
333180 | 0GKS0 | BECTON DICKINSON AND COMPANY | A | A |
FLIS Identification
PMIC | ADPE Code | CRITL Code | DEMIL Code | DEMIL INTG | NIIN Asgt | ESD | HMIC | ENAC | Schedule-B | INC |
---|---|---|---|---|---|---|---|---|---|---|
A | 0 | X | A | 1 | 08/02/2 | A | P | 3006200000 | 3669 |
FLIS Management
MOE | REC Rep Code | Mgmt Ctl | USC | Phrase Code | Phrase Statement |
---|
Demilitarization Codes & Management
DML | PMI | HMIC | ADP | CC | ESDC |
---|
Miscellaneous Management
MOE (S_A) | SOS | AAC | QUP | UI | SLC | CIIC | RC | MCC | SVC |
---|
Management Control Army
MATCAT 1 | MATCAT 2 | MATCAT 3 | MATCAT 4 5 | ARC |
---|
Freight
NMFC | NMFC SUB | UFC | HMC | LTL | LCL | WCC | TCC | SHC | ADC | ACC | ASH | NMF DESC |
---|---|---|---|---|---|---|---|---|---|---|---|---|